Behandlungskonzept des Osteosarkoms

[1]  U. Göbel,et al.  Neoadjuvante Therapie des lokalisierten Osteosarkoms der Extremitäten , 1999 .

[2]  W. Winkelmann,et al.  Malignant tumor of the distal part of the femur or the proximal part of the tibia: endoprosthetic replacement or rotationplasty. Functional outcome and quality-of-life measurements. , 1999, The Journal of bone and joint surgery. American volume.

[3]  K. Unni.  Osteosarcoma of bone , 1998, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[4]  S. Bielack,et al.  Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  J. Bloem,et al.  Preoperative evaluation and monitoring chemotherapy in patients with high-grade osteogenic and Ewing’s sarcoma: review of current imaging modalities , 1998, Skeletal Radiology.

[6]  R. Souhami,et al.  Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup , 1997, The Lancet.

[7]  R Maas,et al.  Tumor size and prognosis in aggressively treated osteosarcoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  J. Høie,et al.  Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival , 1995, Cancer.

[9]  P. Picci,et al.  Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  U. Bode,et al.  Methotrexate pharmacokinetics and prognosis in osteosarcoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  M. Simon,et al.  Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. A long-term oncological, functional, and quality-of-life study. , 1994, The Journal of bone and joint surgery. American volume.

[12]  A. Davis,et al.  Prognostic factors in osteosarcoma: a critical review. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  A. Craft,et al.  A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  G. Rosen,et al.  Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experience , 1992, Cancer.

[15]  R. Simon,et al.  Influence of doxorubicin dose intensity on response and outcome for patients with osteogenic sarcoma and Ewing's sarcoma. , 1991, Journal of the National Cancer Institute.

[16]  A. Stenwig,et al.  Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  S. Leyvraz,et al.  Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high‐dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS‐86) , 1990, Cancer.

[18]  H. Jürgens,et al.  Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  M. Krailo,et al.  The relationship of various aspects of surgical management to outcome in childhood nonmetastatic osteosarcoma: a report from the Childrens Cancer Study Group. , 1988, Journal of pediatric surgery.

[20]  J. Shuster,et al.  The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. , 1986, The New England journal of medicine.

[21]  W. Ebell,et al.  Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  G. Rosen,et al.  Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy , 1982, Cancer.

[23]  W. Enneking,et al.  A System for the Surgical Staging of Musculoskeletal Sarcoma , 1980, Clinical orthopaedics and related research.

[24]  H. Heinzl,et al.  Local and systemic control after ablative and limb sparing surgery in patients with osteosarcoma. , 1999, Clinical orthopaedics and related research.

[25]  A. Huvos,et al.  Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  G Rosen,et al.  Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.